<SEC-DOCUMENT>0001573072-26-000002-index.html : 20260210
<SEC-HEADER>0001573072-26-000002.hdr.sgml : 20260210
<ACCEPTANCE-DATETIME>20260210161506
ACCESSION NUMBER:		0001573072-26-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260210
FILED AS OF DATE:		20260210
DATE AS OF CHANGE:		20260210

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Novack David F
		CENTRAL INDEX KEY:			0001573072
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		26616150

	MAIL ADDRESS:	
		STREET 1:		39 YORKSHIRE DR
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94618

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-02102026_040201.xml
<TEXT>
Document 1 - file: form4-02102026_040201.html

Document 1 - RAW XML: form4-02102026_040201.xml

</DOCUMENT>
</SEC-DOCUMENT>